CA2795671A1 - Signatures genetiques et puces geniques associees a l'administration de courant de radiofrequence electriquement conduit a la peau et procedes et traitements associes a celles-ci - Google Patents
Signatures genetiques et puces geniques associees a l'administration de courant de radiofrequence electriquement conduit a la peau et procedes et traitements associes a celles-ci Download PDFInfo
- Publication number
- CA2795671A1 CA2795671A1 CA2795671A CA2795671A CA2795671A1 CA 2795671 A1 CA2795671 A1 CA 2795671A1 CA 2795671 A CA2795671 A CA 2795671A CA 2795671 A CA2795671 A CA 2795671A CA 2795671 A1 CA2795671 A1 CA 2795671A1
- Authority
- CA
- Canada
- Prior art keywords
- skin
- treatment
- tissue volume
- gene
- radio frequency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract 39
- 238000011282 treatment Methods 0.000 title claims abstract 34
- 108090000623 proteins and genes Proteins 0.000 title claims abstract 32
- 230000002068 genetic effect Effects 0.000 title claims 3
- 230000014509 gene expression Effects 0.000 claims abstract 14
- 230000002500 effect on skin Effects 0.000 claims abstract 7
- 230000003827 upregulation Effects 0.000 claims abstract 5
- 102000008186 Collagen Human genes 0.000 claims abstract 4
- 108010035532 Collagen Proteins 0.000 claims abstract 4
- 108090000695 Cytokines Proteins 0.000 claims abstract 4
- 102000004127 Cytokines Human genes 0.000 claims abstract 4
- 229920001436 collagen Polymers 0.000 claims abstract 4
- 230000002757 inflammatory effect Effects 0.000 claims abstract 4
- 238000007634 remodeling Methods 0.000 claims abstract 4
- 230000015572 biosynthetic process Effects 0.000 claims abstract 3
- 230000001939 inductive effect Effects 0.000 claims abstract 2
- 230000001105 regulatory effect Effects 0.000 claims abstract 2
- 230000001815 facial effect Effects 0.000 claims 11
- 238000011269 treatment regimen Methods 0.000 claims 7
- 239000000523 sample Substances 0.000 claims 4
- 108020004999 messenger RNA Proteins 0.000 claims 3
- 238000001574 biopsy Methods 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 238000011418 maintenance treatment Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 claims 1
- 230000005670 electromagnetic radiation Effects 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 239000002853 nucleic acid probe Substances 0.000 claims 1
- 230000003389 potentiating effect Effects 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32563310P | 2010-04-19 | 2010-04-19 | |
| US61/325,633 | 2010-04-19 | ||
| PCT/US2011/033033 WO2011133538A1 (fr) | 2010-04-19 | 2011-04-19 | Signatures génétiques et puces géniques associées à l'administration de courant de radiofréquence électriquement conduit à la peau et procédés et traitements associés à celles-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2795671A1 true CA2795671A1 (fr) | 2011-10-27 |
Family
ID=44343224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2795671A Abandoned CA2795671A1 (fr) | 2010-04-19 | 2011-04-19 | Signatures genetiques et puces geniques associees a l'administration de courant de radiofrequence electriquement conduit a la peau et procedes et traitements associes a celles-ci |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2561092A1 (fr) |
| JP (1) | JP2013527756A (fr) |
| KR (1) | KR20120137407A (fr) |
| CN (1) | CN102869789B (fr) |
| BR (1) | BR112012026870A2 (fr) |
| CA (1) | CA2795671A1 (fr) |
| MX (1) | MX2012012235A (fr) |
| WO (1) | WO2011133538A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9671410B2 (en) | 2011-01-16 | 2017-06-06 | The Procter & Gamble Company | Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin |
| MX2013010977A (es) | 2011-03-31 | 2013-10-30 | Procter & Gamble | Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica. |
| EP2831274B1 (fr) * | 2012-03-30 | 2017-12-13 | The Procter and Gamble Company | Procédé d'élaboration d'une architecture de données permettant d'identifier des agents agissant sur la pigmentation cutanée |
| JP2015527630A (ja) | 2012-06-06 | 2015-09-17 | ザ プロクター アンド ギャンブルカンパニー | ヘア／頭皮ケア組成物向け化粧剤の同定システム及び方法 |
| JP2015535807A (ja) * | 2012-08-15 | 2015-12-17 | ザ プロクター アンド ギャンブルカンパニー | 皮膚疾患の配列の治療に有効な皮膚活性剤を特定及び評価するためのシステム、モデル、及び方法 |
| WO2016077327A1 (fr) | 2014-11-10 | 2016-05-19 | The Procter & Gamble Company | Compositions de soins personnels comportant deux phases à effet bénéfique |
| US10966916B2 (en) | 2014-11-10 | 2021-04-06 | The Procter And Gamble Company | Personal care compositions |
| WO2016077325A1 (fr) | 2014-11-10 | 2016-05-19 | The Procter & Gamble Company | Compositions de soins personnels comportant deux phases à effet bénéfique |
| CN111225652A (zh) | 2017-10-20 | 2020-06-02 | 宝洁公司 | 气溶胶泡沫洁肤剂 |
| EP3697375B1 (fr) | 2017-10-20 | 2021-12-01 | The Procter & Gamble Company | Nettoyant pour la peau en mousse aérosol |
| WO2020112486A1 (fr) | 2018-11-29 | 2020-06-04 | The Procter & Gamble Company | Méthodes de criblage de produits de soins personnels |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3755560A (en) | 1971-06-30 | 1973-08-28 | Dow Chemical Co | Nongreasy cosmetic lotions |
| US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
| US5202231A (en) | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
| US5525464A (en) | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
| GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| EP0430881A3 (en) | 1989-11-29 | 1991-10-23 | Ciba-Geigy Ag | Photochromic compounds, process for their preparation and their use |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
| US5366443A (en) | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
| EP0636186B1 (fr) | 1992-04-03 | 1998-11-25 | The Perkin-Elmer Corporation | Procede et composition de sondage |
| US5503980A (en) | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5470710A (en) | 1993-10-22 | 1995-11-28 | University Of Utah | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
| GB9401833D0 (en) | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
| US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
| GB9507238D0 (en) | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
| US6430446B1 (en) | 1995-05-05 | 2002-08-06 | Thermage, Inc. | Apparatus for tissue remodeling |
| US5660836A (en) | 1995-05-05 | 1997-08-26 | Knowlton; Edward W. | Method and apparatus for controlled contraction of collagen tissue |
| US6241753B1 (en) | 1995-05-05 | 2001-06-05 | Thermage, Inc. | Method for scar collagen formation and contraction |
| US5755753A (en) | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
| US5661028A (en) | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
| US6228078B1 (en) | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
| US6350276B1 (en) | 1996-01-05 | 2002-02-26 | Thermage, Inc. | Tissue remodeling apparatus containing cooling fluid |
| JP2002515738A (ja) | 1996-01-23 | 2002-05-28 | アフィメトリックス，インコーポレイティド | 核酸分析法 |
| ES2240078T3 (es) | 1999-03-09 | 2005-10-16 | Thermage, Inc. | Aparato para el tratamiento de tejidos. |
| US20020087155A1 (en) * | 1999-08-30 | 2002-07-04 | Underwood Ronald A. | Systems and methods for intradermal collagen stimulation |
| US6702808B1 (en) | 2000-09-28 | 2004-03-09 | Syneron Medical Ltd. | Device and method for treating skin |
| DK1331892T3 (da) * | 2000-10-18 | 2006-10-30 | Mattioli Eng Ltd | Apparat til resurfacing af hud ved hjælp af plasma |
| US6889090B2 (en) | 2001-11-20 | 2005-05-03 | Syneron Medical Ltd. | System and method for skin treatment using electrical current |
| US6662054B2 (en) | 2002-03-26 | 2003-12-09 | Syneron Medical Ltd. | Method and system for treating skin |
| CN1723058A (zh) | 2002-10-07 | 2006-01-18 | 帕洛玛医疗技术公司 | 用于进行光生物刺激的设备 |
| US7643883B2 (en) * | 2005-01-28 | 2010-01-05 | Syneron Medical Ltd. | Device and method for treating skin |
| SI22738A (sl) * | 2008-04-11 | 2009-10-31 | Iskra Medical, D.O.O. | Naprava za radiofrekvenčno krožno globinsko terapijo |
-
2011
- 2011-04-19 CA CA2795671A patent/CA2795671A1/fr not_active Abandoned
- 2011-04-19 KR KR1020127026405A patent/KR20120137407A/ko not_active Ceased
- 2011-04-19 EP EP11718568A patent/EP2561092A1/fr not_active Withdrawn
- 2011-04-19 MX MX2012012235A patent/MX2012012235A/es not_active Application Discontinuation
- 2011-04-19 CN CN201180019773.9A patent/CN102869789B/zh not_active Expired - Fee Related
- 2011-04-19 BR BR112012026870A patent/BR112012026870A2/pt not_active IP Right Cessation
- 2011-04-19 WO PCT/US2011/033033 patent/WO2011133538A1/fr not_active Ceased
- 2011-04-19 JP JP2013506231A patent/JP2013527756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012026870A2 (pt) | 2017-01-10 |
| CN102869789B (zh) | 2015-09-30 |
| WO2011133538A1 (fr) | 2011-10-27 |
| MX2012012235A (es) | 2012-11-23 |
| CN102869789A (zh) | 2013-01-09 |
| JP2013527756A (ja) | 2013-07-04 |
| KR20120137407A (ko) | 2012-12-20 |
| EP2561092A1 (fr) | 2013-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2795671A1 (fr) | Signatures genetiques et puces geniques associees a l'administration de courant de radiofrequence electriquement conduit a la peau et procedes et traitements associes a celles-ci | |
| US10500413B2 (en) | Method and apparatus for treatment of cutaneous and subcutaneous conditions | |
| WO2005070136A3 (fr) | Systeme et procede de regulation a la hausse de l'expression genetique de la proteine morphogenetique osseuse (bmp) dans des cellules osseuses par l'application de champs generes par des signaux electriques et electromagnetiques specifiques et selectifs | |
| EP4065005A4 (fr) | Procédés de régulation de volumes de traitement, de gradients thermiques, de stimulation musculaire et de réponses immunitaires dans des traitements par champs électriques pulsés | |
| US20090317911A1 (en) | System and method for photodynamic cell therapy | |
| WO2013096584A3 (fr) | Électromanipulation de cellules et autres tissus biologiques par champs électriques pulsés à des températures élevées | |
| Argilés | The 2015 ESPEN Sir David Cuthbertson lecture: inflammation as the driving force of muscle wasting in cancer | |
| Ji et al. | Comparison of 5-aminolevulinic acid photodynamic therapy and red light for treatment of photoaging | |
| Huo et al. | Noninvasive electromagnetic fields on keratinocyte growth and migration | |
| Liang et al. | Anti-tumor effects of nanosecond pulsed electric fields in a murine model of pancreatic cancer | |
| ATE490803T1 (de) | Vorrichtung zur behandlung von langen interatrialen verzögerungen | |
| MX2010008765A (es) | Regulacion de expresion de genes de factor de crecimiento de fibroblastos-2 (fgf-2) en celulas vivas con la aplicacion de campos electricos y electromagnetivos especificos y selectivos. | |
| WO2009106969A1 (fr) | Appareil pour traitements cosmétiques, en particulier pour le traitement des vergetures | |
| Levenberg et al. | Treatment of wrinkles and acne scars using the TriFractional, a novel fractional radiofrequency technology—clinical and histological results | |
| JP2013524946A (ja) | 哺乳類の皮膚の状態を調節するための、エネルギー及び局所適用組成物の併用 | |
| JP2010075639A (ja) | 顔面及び頸部の皮膚状態を改善する美容方法及び装置 | |
| Konstantinović et al. | Effects of near-infrared low-level laser stimulation on neuronal excitability | |
| US20230414963A1 (en) | Multi-modal skin treatment device | |
| Yu et al. | Chemogenetic modulation in stroke recovery: A promising stroke therapy Approach | |
| He et al. | Hallmarks of the Aging Skin Microenvironment: Components and Mechanisms | |
| Hossein-Khannazer et al. | Introducing Aurora Kinase A as a Gene Target Against Photoaging: A Network Analysis: Aurora kinase A as a gene target against photoaging | |
| Omata et al. | Modulated expression levels of tyrosine kinases in spontaneously developed melanoma by single irradiation of non-thermal atmospheric pressure plasmas | |
| Kinzel et al. | Comprehensive approaches to increasing Tumor Treating Fields (TTFields) dose at the tumor | |
| Frahm et al. | Temperature controlled laser stimulator for pain research | |
| Viravaidya-Pasuwat et al. | Effect of light-emitting diode wavelengths on human dermal fibroblasts for phototherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |
Effective date: 20150609 |